Tonghua Dongbao Pharmaceutical Co.,Ltd.’s Net Profit Rose 146.9% in First Quarter of 2022

Tonghua Dongbao Pharmaceutical Co.,Ltd. (通化东宝药业股份有限公司) (600867.SH) reported a net profit of 831.2 million yuan in the first quarter of 2022, up 146.9% year-on-year.

Meanwhile, the company posted 887.5 million yuan in revenue, up 7.9% year-on-year.

At the end of the reporting period, it had 7.3 billion yuan in total assets and 302 million yuan in total liabilities, with a liability-to-asset ratio of 4.1%.